Reframe
Reframe Cancer is a CQC-regulated UK provider of nurse-led cancer screening, navigation and support, serving individuals, employers, insurers (notably Unum), and private healthcare providers across the full cancer pathway.
- Company typePrivate
- Founded2012
- HeadquartersBasingstoke, United Kingdom
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Reframe does
Reframe Cancer (legal entity: Harley Street Concierge Ltd) is a Basingstoke-headquartered, CQC-regulated cancer support provider operating exclusively in the United Kingdom. Founded in 2012 by Dame Ann Heron Gloag, the company delivers nurse-led clinical navigation and holistic support across the full cancer pathway — from prevention and screening (six common cancer types) through diagnosis, treatment, follow-up care, and return-to-work — serving individuals, carers, employers, insurers, brokers and private healthcare providers. Its core technology is a digital patient portal (chat, dashboard, messaging, diary, case management, secure file storage) supported by an information hub for resources and webinars; the firm also operates the Voices for Cancer patient involvement group to inform service design.
Reframe earns revenue through three primary streams: (1) annual individual subscription plans priced at £525, £1,995 and £3,295 for 4, 16 and 28 hours of support respectively; (2) employer-sponsored B2B contracts of varying size; and (3) channel partnerships — most notably with insurer Unum — that embed cancer support into critical illness, group risk and PMI policies, covering over 1.1 million lives. Distribution combines direct enterprise sales to HR and benefits leaders, a direct-to-consumer self-serve channel on reframe.co.uk (Stripe and HubSpot Forms for payments), and broker and healthcare provider partnerships (e.g., Amethyst Radiotherapy). The company is privately held, founder-controlled with no disclosed venture or private equity investment, and operates at a headcount of 11–50 employees.
Reframe firmographics
Firmographics- Name
- Reframe
- Legal name
- Harley Street Concierge Ltd
- Website
- https://reframe.co.uk
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Reframe Cancer is a CQC-regulated UK provider of nurse-led cancer screening, navigation and support, serving individuals, employers, insurers (notably Unum), and private healthcare providers across the full cancer pathway.
- Ownership category
- akta.pro rank
Reframe industry classification
Industry- Product category
- Cancer Care Services
- NAICS
- Other Individual and Family Services (624190)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Oncology Remote Symptom Monitoring & Care Navigation (HLALAFAD)
Keywords
Where Reframe is headquartered
LocationHeadquarters
- HQ city
- Basingstoke
- HQ country
- United Kingdom
- HQ region
- Europe
Offices1 record
Markets served
Reframe business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Marketing or Sales, Others
Revenue model
- Individual Subscription Plans: Annual subscription plans for individuals offering tiered hours of support (4, 16, or 28 hours) over 12 months. Includes access to Cancer Nurse Specialists, Cancer Support Managers, patient portal, and wellbeing assessments. Prices range from £525 to £3,295 per year including VAT.
- Enterprise/B2B Corporate Plans: Employer-sponsored cancer support programs offered as employee benefits. Pricing varies by organization size and coverage level. Supports both NHS and private treatment pathways.
- Insurance/Intermediary Partnerships: Value-add cancer support services integrated into insurance policies (e.g., Unum critical illness and health insurance). Services provided to policyholders as a benefit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | 4 hour plan - £525/year |
| Subscription | Annual | 16 hour plan - £1,995/year |
| Subscription | Annual | 28 hour plan - £3,295/year |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Reframe product offering
Product offeringCore offering
Reframe provides nurse-led, CQC-regulated cancer support services across the entire cancer pathway, from prevention and screening through diagnosis, treatment, and life after cancer. Its portfolio includes cancer screening, cancer navigation, care for carers, rapid workplace response, and workplace training, delivered by Cancer Nurse Specialists and Cancer Support Managers via phone, video, chat, email, and a digital patient portal. Services are sold both to individuals via tiered annual subscription plans and to employers, insurers, brokers, and private healthcare providers as enterprise solutions.
Product overview
Reframe Cancer is a CQC-regulated cancer support organisation offering a unified portfolio of services across the entire cancer pathway—from prevention and screening to diagnosis, treatment, and life after cancer. The core offering consists of Cancer Screening (launched 2025), Cancer Navigation, Care for Carers, Rapid Workplace Response, and CancerWise Workplace Essentials Training. These are delivered through multiple channels: direct individual support plans (4, 16, and 28-hour tiers priced from £525 to £3,295/year), corporate/employer packages, insurer integrations, broker solutions, and private healthcare provider partnerships. Access is enabled via a Patient Portal and Information Hub digital platform, supported by Cancer Nurse Specialists and Cancer Support Managers. The Voices for Cancer Group provides patient involvement in service design.
Differentiator
Problem solved
Functional benefit
Products and services
- Cancer Screening Early detection screening service offering personalised cancer risk assessment, health guidance and screening eligibility for 6 common cancer types. Available as flexible self-pay or employer-funded options for organisations and individuals.
- Cancer Navigation Expert navigation service helping patients access NHS and private treatment for optimal outcomes, with clinical guidance from oncology nurses throughout the cancer pathway including diagnosis, treatment decision support, second opinions, and appointment coordination.
- Care for Carers
Quantifiable outcome
- Patients can return to work up to 2 months faster with supported treatment decisions
- +2 more outcomes
Companies that use Reframe
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles4 records
Reframe technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration5 records
Feature2 records
Reframe partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and supporting.
- UnumcoreUnum provides Reframe cancer support services as part of their employee benefits and critical illness cover policies. This partnership covers over 1.1 million lives, offering policyholders access to cancer navigation, screening, and support throughout the cancer pathway.
- Amethyst RadiotherapycorePartnership with Amethyst Radiotherapy to manage caseloads efficiently while ensuring patients receive quality focused treatment. Amethyst Clinical Operations Manager Gretchen Tenorio cited the partnership as invaluable.
- KlaritysupportingKlarity is a screening and oncology service provider partnering with Reframe for webinar content on cancer prevention and early detection, combining clinical expertise with screening guidance.
Scale indicators4 records
Recent moves11 records
Expansion highlights6 records
Reframe competitors and assessment
Company assessmentBroad incumbents
- Vitality Health: UK health and life insurer with employer-sponsored cancer cover and value-added cancer support services. Comparable to Reframe's insurer partnership GTM and direct-to-employer benefits model.
- Nuffield Health: UK healthcare charity providing private hospitals, health assessments, and corporate wellbeing programs including cancer screening. Comparable to Reframe across screening and employer wellbeing offerings, with much broader scale.
- Bupa: Major UK private health insurer offering cancer cover and access to cancer support services through employer and individual plans. Overlaps with Reframe's employer/insurer channel; broader portfolio but less specialized in navigation.
- Macmillan Cancer Support: Largest UK cancer charity providing information, financial, and emotional support across the cancer pathway, plus corporate partnerships. Comparable to Reframe in scope of cancer support and NHS navigation; operates at much greater scale via charity funding rather than paid subscriptions.
- HCA Healthcare UK: Major private hospital group in the UK providing cancer treatment and patient support services to private medical insurers and corporates. Comparable to Reframe's healthcare provider partnership GTM (like Amethyst Radiotherapy), but at much larger clinical scale.
- AXA Health: UK private medical insurer providing cancer cover and support services as part of employer and individual health policies. Comparable to Reframe's insurer channel motion; broader general health rather than cancer-specific.
- Health Hero: UK digital health and virtual care provider offering condition-specific support including cancer navigation as part of employer and insurer contracts. Comparable business model around employer/insurer distribution of nurse-led support.
Direct peers
- Perci Health: UK-based virtual cancer clinic delivering personalized support from oncology nurses and experts via digital tools, with both employer and individual offerings. Closely mirrors Reframe's B2B/B2C nurse-led digital cancer support model.
- Careology: UK-based digital cancer care platform providing patient-facing apps and remote symptom monitoring for people going through cancer treatment. Directly comparable to Reframe in offering digital, nurse-supported cancer navigation across the treatment pathway.
Emerging players
- Geneva Health Solutions / Klarity: Klarity is a UK cancer screening and oncology services partner that already co-produces webinar content with Reframe on early detection. Comparable in cancer screening focus and an existing commercial partner.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
Reframe social profiles
Digital presenceReframe compliance and trust
Trust signalCompliance4 records
Reframe financial estimates
Financial estimateRevenue estimate
Valuation estimate
Reframe leadership team
Management profileNumber of profiles
Profiles12 records
Reframe funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Reframe M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Reframe
What does Reframe do?
Reframe provides nurse-led, CQC-regulated cancer support services across the entire cancer pathway, from prevention and screening through diagnosis, treatment, and life after cancer. Its portfolio includes cancer screening, cancer navigation, care for carers, rapid workplace response, and workplace training, delivered by Cancer Nurse Specialists and Cancer Support Managers via phone, video, chat, email, and a digital patient portal. Services are sold both to individuals via tiered annual subscription plans and to employers, insurers, brokers, and private healthcare providers as enterprise solutions.
Is Reframe a public or private company?
Reframe is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Reframe founded?
Reframe was founded in 2012. It employs 11 to 50 people.
Where is Reframe based?
Reframe is headquartered in Basingstoke, United Kingdom, in the Europe region.
How does Reframe make money?
Three revenue lines are on record. Individual Subscription Plans are the primary driver. The others are enterprise/B2B Corporate Plans and insurance/Intermediary Partnerships.
Who are Reframe's main competitors?
Broad incumbents on record are Vitality Health, Nuffield Health, Bupa, Macmillan Cancer Support, HCA Healthcare UK, AXA Health and Health Hero. Direct peers are Perci Health and Careology. Geneva Health Solutions / Klarity is listed as an emerging player.
Does Reframe have an API?
No public API is recorded for Reframe.
What industry is Reframe in?
Reframe's product category is Cancer Care Services. Its primary akta.pro industry code is HLALAFAD, Oncology Remote Symptom Monitoring & Care Navigation. Its NAICS code is 624190 and its SIC code is 8000.